Richard Eisenstadt
2014 - Neos Therapeutics
In 2014, Richard Eisenstadt earned a total compensation of $421.6K as Chief Financial Officer at Neos Therapeutics.
Compensation breakdown
| Bonus | $77,627 |
|---|---|
| Option Awards | $129,743 |
| Salary | $187,692 |
| Other | $26,500 |
| Total | $421,562 |
Eisenstadt received $187.7K in salary, accounting for 45% of the total pay in 2014.
Eisenstadt also received $77.6K in bonus, $129.7K in option awards and $26.5K in other compensation.
Rankings
In 2014, Richard Eisenstadt's compensation ranked 10,846th out of 13,032 executives tracked by ExecPay. In other words, Eisenstadt earned more than 16.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,846 out of 13,032 | 17th |
Division Manufacturing | 4,146 out of 4,966 | 17th |
Major group Chemicals And Allied Products | 1,431 out of 1,686 | 15th |
Industry group Drugs | 1,150 out of 1,365 | 16th |
Industry Pharmaceutical Preparations | 881 out of 1,043 | 16th |
Source: SEC filing on April 26, 2016.
Eisenstadt's colleagues
We found one more compensation record of an executive who worked with Richard Eisenstadt at Neos Therapeutics in 2014.
2014
Vipin Garg
Neos Therapeutics
Chief Executive Officer
News
PharmAthene CEO Vipin Garg's 2022 pay rises 9% to $2.9M
August 16, 2023
PharmAthene CEO Vipin Garg's 2021 pay jumps 83% to $2.6M
August 16, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
Neos Therapeutics CEO Gerald McLaughlin's 2019 pay falls 56% to $1.4M
April 21, 2020
Neos Therapeutics CEO Gerald McLaughlin receives $3.2M in 2018
April 24, 2019